In the December issue of Infection Control and Hospital Epidemiology, guidelines have been proposed by epidemiologists from Beaumont Health System to reduce the risk of infection from contaminated gels. The recommendations are based on the authors own experiences with an outbreak traced to contaminated ultrasound transmission gel.
In December 2011, researchers uncovered an unusual cluster of Pseudomonas aeruginosa in a cardiovascular surgery intensive care unit during routine infection control surveillance. The outbreak was found to have stemmed from bottles of ultrasound transmission gel that were contaminated during the manufacturing process and that were being used for intraoperative transesophageal echocardiography. This information ultimately led to a national recall of the product.
These gels contain parabens or methyl benzoate that inhibit, but not kill, the growth of bacteria. However, past studies have demonstrated that ultrasound gels do not have antimicrobial properties and could serve as a medium for bacterial growth. Contaminated gels have been found to be the source of other outbreaks of infection in the last two decades.
After our investigation of the Pseudomonas outbreak last year linked the source of the outbreak to contaminated ultrasound gel, we were surprised to find that very little guidance is available on appropriate uses for different ultrasound gel products, says Susan Oleszkowicz, MPH, lead author of the paper.
In their article the authors outline initial guidelines for recommended uses of ultrasound transmission gels, calling on manufacturers of ultrasound gel and professional societies to take an active role in developing recommendations for appropriate and intended use of products.
Suggestions include: 1) the need for sterile, single-dose ultrasound gel in any invasive procedure or procedures involving non-intact skin or fresh surgical wounds; 2) sterile, single-dose ultrasound gel should be used with newborns or critically ill children; 3) multi-dose, non-sterile gel can still be used on intact skin, but containers should be sealed appropriately when not in use, and replaced when empty, rather than refilled.Â
Â
Reference: Oleszkowicz SC, et al. Infections Associated with Use of Ultrasound Transmission Gel: Proposed Guidelines to Minimize Risk. Infection Control and Hospital Epidemiology 33:12 (December 2012).
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.